Realm Therapeutics plc American Depositary Shares
RLM
RLM was delisted on the 30th of July, 2019.
4 hedge funds and large institutions have $2.56M invested in Realm Therapeutics plc American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
39% less capital invested
Capital invested by funds: $4.23M → $2.56M (-$1.67M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WF
WealthTrust Fairport
Cleveland,
Ohio
|
+$5.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.24K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $1.89M | – | – | – |
|
|
BI
2
BVF Inc
San Francisco,
California
| $668K | – | – | – |
|
|
WF
3
WealthTrust Fairport
Cleveland,
Ohio
| $4K | +$5.63K | +2,280 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | -$3.24K | -1,311 | -70% |
|
RLM Hedge Fund Activity: Q4 2018 in Review
4 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Realm Therapeutics plc American Depositary Shares (RLM) for Q4 2018, worth a combined $2.56M — down 39% from $4.23M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new RLM positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was WealthTrust Fairport, opening a new position worth an estimated $5.63K. The largest seller was UBS Group, cutting an estimated $3.24K.
- 4 institutional investors held Realm Therapeutics plc American Depositary Shares (RLM) as of Q4 2018, up from 3 in Q3 2018.
- Funds reported $2.56M of Realm Therapeutics plc American Depositary Shares stock for Q4 2018, down 39% quarter-over-quarter.
- 1 fund opened new Realm Therapeutics plc American Depositary Shares positions in Q4 2018 and 0 closed out, a net change of +1 holder.
- The largest Realm Therapeutics plc American Depositary Shares buyer in Q4 2018 was WealthTrust Fairport, an estimated $5.63K added.
- The largest Realm Therapeutics plc American Depositary Shares seller in Q4 2018 was UBS Group, an estimated $3.24K sold.
Based on aggregated 13F filings for Q4 2018.